MR1 抗体 (AA 150-253)
Quick Overview for MR1 抗体 (AA 150-253) (ABIN7622712)
抗原
See all MR1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 150-253
-
原理
- Mr1 Polyclonal Antibody
-
产品特性
- The Mr1 Polyclonal Antibody (Species: Human) has been validated for the following applications: ELISA, WB, IHC, IF.
-
纯化方法
- Protein G Purified
-
纯度
- >95%
-
免疫原
- Recombinant Human Major Histocompatibility Complex Class I-Related Gene Protein
-
亚型
- IgG
-
-
anti-Major Histocompatibility Complex, Class I-Related (MR1) (AA 201-300) antibody
MR1 适用: 人 ELISA, WB, IF 宿主: 小鼠 Monoclonal 5B5 unconjugated
anti-Major Histocompatibility Complex, Class I-Related (MR1) (AA 312-341), (C-Term) antibodyMR1 适用: 人 WB 宿主: 兔 Polyclonal RB37199 unconjugated
anti-Major Histocompatibility Complex, Class I-Related (MR1) (AA 150-253) antibodyMR1 适用: 人 ELISA, WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Major Histocompatibility Complex, Class I-Related (MR1) (AA 20-260) antibodyMR1 适用: 人 WB, IF 宿主: 兔 Polyclonal unconjugated
anti-Major Histocompatibility Complex, Class I-Related (MR1) (AA 150-253) antibodyMR1 适用: 人, 小鼠 ELISA, WB, IHC, IF/ICC 宿主: 兔 Polyclonal unconjugated
anti-Major Histocompatibility Complex, Class I-Related (MR1) (AA 20-260) antibodyMR1 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Major Histocompatibility Complex, Class I-Related (MR1) (AA 201-300) antibodyMR1 适用: 人 ELISA, WB 宿主: 小鼠 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- Lot specific
-
缓冲液
- Preservative: 0.03 % Proclin 300, Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
- MR1 (Major Histocompatibility Complex, Class I-Related (MR1))
-
别名
- MR1
-
UniProt
- Q95460
-
途径
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
抗原
-
